ClinVar Miner

Submissions for variant NM_001105206.3(LAMA4):c.343G>A (p.Asp115Asn)

gnomAD frequency: 0.00001  dbSNP: rs781919095
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000219177 SCV000270330 likely benign not specified 2015-07-16 criteria provided, single submitter clinical testing p.Asp115Asn in exon 4 of LAMA4: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of n ote, 3 mammals (star-nosed mole, cape elephent shrew, aardvark) have an asparagi ne (Asn) at this position despite high nearby amino acid conservation. In additi on, computational prediction tools do not suggest a high likelihood of impact to the protein. This variant has been identified in 1/66678 European chromosomes b y the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org).
Invitae RCV000555552 SCV000654012 uncertain significance Dilated cardiomyopathy 1JJ 2023-11-04 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 115 of the LAMA4 protein (p.Asp115Asn). This variant is present in population databases (rs781919095, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with LAMA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 227477). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002453760 SCV002615201 uncertain significance Cardiovascular phenotype 2019-11-01 criteria provided, single submitter clinical testing The p.D115N variant (also known as c.343G>A), located in coding exon 3 of the LAMA4 gene, results from a G to A substitution at nucleotide position 343. The aspartic acid at codon 115 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.